抑絲蛋白1(PFN1)多克隆抗體
Polyclonal Antibody to Profilin 1 (PFN1)
Epididymis tissue protein Li 184a
- 編號PAC233Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPC233Hu01-抑絲蛋白1(PFN1)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度0.43mg/mL
- 且適物種Sus scrofa; Porcine (Pig,豬)
- 應用WB
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
特異性
該抗體是針對PFN1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別PFN1。
用法
Western blotting: 0.01-2μg/mL
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
贈品
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPC233Hu01 | 抑絲蛋白1(PFN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC233Hu01 | 抑絲蛋白1(PFN1)多克隆抗體 | WB |
FAC233Hu11 | 抗抑絲蛋白1(PFN1)多克隆抗體(標記) | FCM |
MAC233Hu22 | 抑絲蛋白1(PFN1)單克隆抗體 | WB; IHC; ICC; IP. |
SEC233Hu | 抑絲蛋白1(PFN1)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC233Hu | 抑絲蛋白1(PFN1)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
PLoS?One | Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation [Pubmed:26889680] |
Electrophoresis | Comparative proteomics analysis of microvesicles in human serum for the evaluation of osteoporosis [Pubmed: 31081149] |
European Review for Medical and Pharmacological Sciences | Evaluation of profilin 1 as a biomarker in myocardial infarction [Pubmed: 32767339] |
Clinical and Experimental Medicine | Reduced perforin release from T cells as a mechanism underlying hypothermia‐mediated neuroprotection [] |
ЦИркУлИрУЮщИе актИН-СвЯЗЫваЮщИе БелкИ ПрИ ПроГреССИроваНИИ рака ГортаНИ И ГортаНоГлоткИ [] | |
The level of cytoskeleton remodeling proteins in the blood serum and the expression of their mRNA in the tumor tissue in metastasis of the larynx and hypopharynx cancer [] | |
Biomed Pharmacother | Intravenous ferric carboxymaltose does not provide benefits in reperfused acute myocardial infarction in the rat with normal iron status [34243097] |
留言咨詢